Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
about
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@ast
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@en
type
label
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@ast
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@en
prefLabel
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@ast
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@en
P2093
P2860
P50
P356
P1433
P1476
Cryptic BCR-ABL fusion gene as ...... and influence on TKIs therapy.
@en
P2093
Gaia Ameli
Giulia Marzocchi
Mario Tiribelli
Michele Cavo
P2860
P304
29906-29913
P356
10.18632/ONCOTARGET.15369
P407
P50
P577
2017-02-16T00:00:00Z